Multiple sclerosis and COVID-19

by Jan Mares, Hans-Peter Hartung
Published 2020-09-01

Atacicept: targeting B cells in multiple sclerosis

by Hans-Peter Hartung, Bernd C. Kieseier
Published 2010-07-01

Interferon gamma and sonic hedgehog signaling are required to dysregulate murine neural stem/precursor cells.

by Janine Walter, Hans-Peter Hartung, Marcel Dihné
Published 2012-01-01

Tissue mRNA expression in rat of newly described matrix metalloproteinases

by FABIÁN BERNAL, HANS-PETER HARTUNG, BERND C KIESEIER
Published 2005-01-01

Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine

by Clemens Warnke, Heinz Wiendl, Hans-Peter Hartung, et al
Published 2010-06-01

Prominent T-Cell Responses against the Acetylcholine Receptor ε Subunit in Myasthenia Gravis

by Oliver Neuhaus, Karl-Heinz Wiesmüller, Hans-Peter Hartung, Heinz Wiendl
Published 2019-01-01

Comparison of different optomotor response readouts for visual testing in experimental autoimmune encephalomyelitis-optic neuritis

by Christina Hecker, Michael Dietrich, Andrea Issberner, Hans-Peter Hartung, Philipp Albrecht
Published 2020-07-01

Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies

by Verena I. Leussink, Hans-Peter Hartung, Bernd C. Kieseier, Mark Stettner
Published 2016-07-01

Type O blood group associates with higher anti‐JC polyomavirus antibody levels

by Pia Frenken, Hans‐Peter Hartung, Tomas Olsson, Ortwin Adams, Clemens Warnke
Published 2021-08-01

Age-dependent modulation of cortical transcriptomes in spinal cord injury and repair.

by Anne Jaerve, Fabian Kruse, Katharina Malik, Hans-Peter Hartung, Hans Werner Müller
Published 2012-01-01

Review: Pathogenesis and treatment of immune-mediated neuropathies

by Helmar C. Lehmann, Gerd Meyer zu Horste, Bernd C. Kieseier, Hans-Peter Hartung
Published 2009-07-01

Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.

by Manda V Sasidhar, Sai Krishnaveni Chevooru, Oliver Eickelberg, Hans-Peter Hartung, Oliver Neuhaus
Published 2017-01-01

Teriflunomide promotes oligodendroglial differentiation and myelination

by Peter Göttle, Anastasia Manousi, David Kremer, Laura Reiche, Hans-Peter Hartung, Patrick Küry
Published 2018-03-01

Outcome and Treatment Effects in Stroke Associated with Acute Cervical ICA Occlusion.

by Michael Gliem, John-Ih Lee, Aurica Barckhan, Bernd Turowski, Hans-Peter Hartung, Sebastian Jander
Published 2017-01-01

Merits and culprits of immunotherapies for neurological diseases in times of COVID-19

by Marc Pawlitzki, Uwe K. Zettl, Tobias Ruck, Leoni Rolfes, Hans-Peter Hartung, Sven G. Meuth
Published 2020-06-01

Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity

by Verena Isabell Leussink, Leila Husseini, Clemens Warnke, Erasmia Broussalis, Hans-Peter Hartung, Bernd C. Kieseier
Published 2012-09-01

An unmet clinical need: roads to remyelination in MS

by Peter Göttle, Moritz Förster, Vivien Weyers, Patrick Küry, Konrad Rejdak, Hans-Peter Hartung, David Kremer
Published 2019-07-01

The Molecular Basis for Remyelination Failure in Multiple Sclerosis

by Joel Gruchot, Vivien Weyers, Peter Göttle, Moritz Förster, Hans-Peter Hartung, Patrick Küry, David Kremer
Published 2019-08-01

The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies

by Thomas Dehmel, Angela Janke, Hans-Peter Hartung, Hans-Hilmar Goebel, Heinz Wiendl, Bernd C. Kieseier
Published 2007-03-01

Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing m...

by Peter Rieckmann, Fedor Heidenreich, Michael Sailer, Uwe K. Zettl, Norbert Zessack, Hans-Peter Hartung, Ralf Gold
Published 2012-01-01